Spinal microglia are dispensable for the development of opioid-induced hyperalgesia
- 1University of Alberta
Abstract
Adverse side effects of chronic opioid use, including analgesic tolerance, opioid-induced hyperalgesia, and addiction, are serious clinical challenges for pain management and opioid deprescribing. Microglia have been implicated in the development of these adverse effects, but the extent to which opioids alter microglia and the mechanisms behind opioid effects on microglia are poorly understood. We performed morphological and single-cell transcriptomic analysis on spinal microglia from opioid-withdrawn and saline-treated mice, and found that while morphological changes recapitulated prior reports, transcriptomic changes in these cells were modest. Furthermore, peripherally, but not centrally, restricted opioid administration was sufficient to induce both hyperalgesia and microglial morphological changes in mice. Finally, complete loss of microglia in Csf1r{Delta}{Delta}FIRE mice did not prevent the development of opioid-induced hyperalgesia, analgesic tolerance, and somatic withdrawal symptoms. These data argue against any microglial involvement in the development of these phenomena.
Related
- High-frequency stimulation–induced secondary hyperalgesia shifts temporal order judgment and increases precuneus nodal degree in healthy adults
- NANOG is dispensable for hypoblast but essential for embryonic disc development during conceptus elongation in sheep
- The microglia-derived protein Sema4ab attenuates regenerative neurogenesis after spinal cord injury in zebrafish
- tACS suppresses M1 polarization of microglia after spinal cord injury through the cGMP-PKG signaling pathway
- Reelin doses normalizing behavioural alterations induced by repeated corticosterone avoid eliciting neuroinflammation-associated morphology in hippocampal microglia
BibTeX
@misc{nickols2026spinal,
title = {{Spinal microglia are dispensable for the development of opioid-induced hyperalgesia}},
author = {J. E. R. Nickols and T. Wilson and K. V. Lee and J. M. Clark and A. C. Wass and C. S. Baaklini and C. A. Faig and M. F. S. Ho and K. M. Souter and B. Szulc and M. E. Traetta and J. R. Plemel and A. M. W. Taylor},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.24.753592},
url = {https://www.biorxiv.org/content/10.64898/2026.09.24.753592v1},
note = {CC BY-ND},
}
RIS
TY - UNPB
TI - Spinal microglia are dispensable for the development of opioid-induced hyperalgesia
AU - J. E. R. Nickols
AU - T. Wilson
AU - K. V. Lee
AU - J. M. Clark
AU - A. C. Wass
AU - C. S. Baaklini
AU - C. A. Faig
AU - M. F. S. Ho
AU - K. M. Souter
AU - B. Szulc
AU - M. E. Traetta
AU - J. R. Plemel
AU - A. M. W. Taylor
PY - 2026
DA - 2026/09/24
PB - bioRxiv
DO - 10.64898/2026.09.24.753592
UR - https://www.biorxiv.org/content/10.64898/2026.09.24.753592v1
AB - Adverse side effects of chronic opioid use, including analgesic tolerance, opioid-induced hyperalgesia, and addiction, are serious clinical challenges for pain management and opioid deprescribing. Microglia have been implicated in the development of these adverse effects, but the extent to which opioids alter microglia and the mechanisms behind opioid effects on microglia are poorly understood. We performed morphological and single-cell transcriptomic analysis on spinal microglia from opioid-withdrawn and saline-treated mice, and found that while morphological changes recapitulated prior reports, transcriptomic changes in these cells were modest. Furthermore, peripherally, but not centrally, restricted opioid administration was sufficient to induce both hyperalgesia and microglial morphological changes in mice. Finally, complete loss of microglia in Csf1r{Delta}{Delta}FIRE mice did not prevent the development of opioid-induced hyperalgesia, analgesic tolerance, and somatic withdrawal symptoms. These data argue against any microglial involvement in the development of these phenomena.
ER -